Launching a new therapy requires timely visibility into commercial performance, patient readiness, and key launch milestones. A global biotechnology company needed to track product-specific launch KPIs while simultaneously understanding patient eligibility and demand signals. However, critical launch metrics and patient data were spread across multiple sources, making it difficult for launch stakeholders to access a unified and timely view of launch readiness.
Infocepts partnered with the organization to build a Drug Launch Readiness Analytics Platform that connected launch performance and patient eligibility data through automated pipelines, centralized dashboards, and proactive KPI alerts. The solution provided stakeholders with a trusted, real-time view of launch progress, helping teams identify risks earlier, improve visibility, and make faster business decisions.
The organization’s therapy launch data was distributed across multiple systems and reports, requiring manual effort to gather, reconcile, and analyze information. Product-specific launch KPIs and patient eligibility data existed independently, making it difficult for stakeholders to monitor launch performance and anticipate patient demand in a single view. Reports often arrived late due to manual data collection processes, while the absence of proactive alerts meant that KPI shifts and launch risks frequently went unnoticed until scheduled reviews.
Infocepts addressed these challenges by implementing a Drug Launch Readiness Analytics solution featuring automated data pipelines, custom launch KPI dashboards, patient eligibility tracking, and proactive KPI alerts, enabling timely visibility, reduced data lag, and more effective launch decision-making.
The transformation delivered tangible, measurable results:
One View
Automated
Proactive
Reduced
The Enterprise AI & Data Transformation Partner. Delivering measurable business impact globally.
#1 on Gartner Peer Insights · 97.2% client retention
